Search

everythinglearnresearchcommunity

for

Search:↓

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Duodenal mucosal resurfacing did not improve insulin sensitivity or reproductive function in women with PCOS.

Dihydrotestosterone gel before hypospadias surgery led to less scarring but raised concerns about potential psychological effects and skin changes.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.

A new method was developed to accurately measure enzyme activity related to prostate health.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Lower SHBG levels may increase the risk of PCOS.

Chromosomal differences affect how muscle cells respond to testosterone.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Hair diameter diversity helps assess hair loss, but its standard measure varies by individual and ethnicity.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

A gene deletion in DSG4 causes sparse hair in some Pakistani families.

Early diagnosis and treatment are crucial for complex medical conditions.

PSA can help diagnose high androgen levels in women.

A certain gene variation is linked to a higher risk of polycystic ovarian syndrome in South Indian women.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Affected males are born with ambiguous genitalia, raised as females, but develop male traits at puberty due to enzyme deficiency.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

The same genetic mutation in Sjögren-Larsson syndrome can lead to different levels of severity, suggesting other factors influence the symptoms.

3βHSD2 is not useful for diagnosing PCOS.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

A rare genetic mutation causes resistance to vitamin D, leading to severe rickets and requiring high doses of calcium and vitamin D for treatment.

SFRP2 and PTGDS may be key factors in female hair loss.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Using single dermal papillae is unreliable for analyzing androgen metabolism in hair follicles.